SAN MATEO, Calif. – October 23, 2024 – BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it has been named the Manufacturer of the Year by the National Association of Specialty Pharmacy (NASP). This peer-nominated and reviewed award recognizes BeiGene’s commitment to advancing patient care, driving innovation and upholding NASP’s values of collaboration and patient-centered excellence in the specialty pharmacy landscape.

“We are honored to be recognized by NASP with the Manufacturer of the Year Award, a reflection of our commitment to working collaboratively with specialty pharmacy stakeholders to drive better clinical outcomes that benefit patients,” said Matt Shaulis, General Manager, North America at BeiGene. “This award underscores our dedication and vision to enhancing the patient journey by delivering impactful, affordable and accessible cancer treatments to reach as many patients as possible worldwide.”                

The Manufacturer of the Year Award is presented to a pharmaceutical or biotechnology manufacturer that best demonstrates a strong commitment to collaborating with specialty pharmacy stakeholders to deliver enhanced clinical and economic outcomes, while making a positive impact on the patient journey. BeiGene was evaluated and recognized based on its innovation and leadership, cost management, specialty pharmacy business model acumen, community involvement and advocacy. The award was announced earlier this month at NASP's 2024 Annual Meeting & Expo in Nashville, TN, which brought together industry leaders, specialty pharmacy professionals and patient advocates.

About BeiGene
BeiGene is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 10,000 colleagues spans five continents. To learn more about BeiGene, please visit www.beigene.com and follow us on LinkedIn, X (formerly known as Twitter), Facebook and Instagram.

About the National Association of Specialty Pharmacy (NASP)

NASP is a 501(c)(6) trade organization and is the only non-profit national association representing all stakeholders in the specialty pharmacy industry. The mission of NASP is to elevate the practice of specialty pharmacy by developing, delivering, and promoting continuing professional education and specialty certification while advocating for public policies that ensure patients have appropriate access to specialty medications in tandem with critical services. NASP members include the nation’s leading independent specialty pharmacies, pharmaceutical and biotechnology manufacturers, group purchasing organizations, patient advocacy groups, integrated delivery systems and health plans, technology and data management vendors, wholesalers/distributors, and practicing pharmacists. With more than 3,000 members, NASP is unifying the voices of specialty pharmacy in the United States.

To access BeiGene media resources, please visit our News & Media site.